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Abstract
Transient receptor potential (TRP) channels sense and transduce environmental stimuli into Ca2+ transients that in
turn induce responses essential for cell function and adaptation. These non-selective channels with variable Ca2+
selectivity are grouped into seven different subfamilies containing 28 subtypes based on differences in amino acid
sequence homology. Many of these subtypes are expressed in the eye on both neuronal and non-neuronal cells
where they affect a host of stress-induced regulatory responses essential for normal vision maintenance. This article
reviews our current knowledge about the expression, function and regulation of TRPs in different eye tissues. We
also describe how under certain conditions TRP activation can induce responses that are maladaptive to ocular
function. Furthermore, the possibility of an association between TRP mutations and disease is considered. These
findings contribute to evidence suggesting that drug targeting TRP channels may be of therapeutic benefit in a
clinical setting. We point out issues that must be more extensively addressed before it will be possible to decide
with certainty that this is a realistic endeavor. Another possible upshot of future studies is that disease process
progression can be better evaluated by profiling changes in tissue specific functional TRP subtype activity as well as
their gene and protein expression.
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TRP channel characteristics
In 1969, a Drosophila mutant was identified having de-
fective vision (abnormal electroretinogram) in which
light-induced channel activation elicited a transient ra-
ther than sustained membrane voltage depolarization
[1–3]. About 20 years later, this aberrant behavior was
attributed to a mutant TRP gene. Subsequent to its clon-
ing in 1989 it was realized that a mutation in the trp
gene underlay this aberrant light response. Specifically,
cloning and sequencing of the Drosophila trp gene
showed that its 4.1-kb RNA transcript encodes a
1275—amino acid protein [1, 4]. Since extracellular ap-
plication of the non-specific Ca2+ channel blocker
lanthanum-III-chloride (La3+) to the retina of the blowfly
Calliphora caused extreme weakening of the receptor
potential to the dark baseline level during a light pulse
[1]. This response showed that trp is a light sensitive
channel. This breakthrough led to the realization that
other channels with unique structures had nevertheless
a signature TRP sequence (i.e. TRP box).
These TRP box containing channels are characteristic
of a superfamily in mammals derived from 28 different
genes. They are further categorized by separating them
into six different subfamilies based on their sensitivity to
activation by different stimuli. TRP receptor channel
activation in different ocular tissues is essential for not
only visual processing, but also the maintenance of
normal health. These non-selective channels transduce
environmental stresses into cell signaling events control-
ling different adaptive responses needed for offsetting
such challenges. Emerging indications of their import-
ance has prompted efforts to identify lead compounds,
which can modulate their activation profiles in order to
counter losses in cellular function caused by tissue
injury, touch, fluctuations in ambient temperature, pH
as well as medium osmolarity, hormonal exposure and
pathogen infiltration. This endeavor can lead to the de-
velopment of novel strategies for improving the treat-
ment of different ocular diseases in a clinical setting.
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TRPs are non-selective cation channels with variable
Ca2+permselectivity. Their activation by a vast array of
different stimuli elicits intracellular Ca2 transients lead-
ing to downstream stimulation of various signaling
pathways as well as in some cases transactivating other
receptor types. It is still unclear how TRP responses en-
code through modulation of Ca2+ influx a myriad of
downstream signaling events triggering response forma-
tion [5–7].
We review here TRP functional involvement in cornea,
conjunctival epithelium, uvea, lens and retina. It is our
intent that the reader will a) more fully appreciate their
importance in maintaining ocular function; b) realize
that changes in TRP functional expression can underlie
ocular disease.
TRP channel channelopathies and nomenclature
TRPs sense diverse environmental stimuli including am-
bient temperature, changes in membrane stress, declines
in pH, exposure to anisosmotic media and environmen-
tal ligands as well as kinase-induced channel phosphor-
ylation [8–10]. Changes in their function due to
mutation [so-called (TRP) channelopathies] are associ-
ated with human diseases such as cancer [6, 11–13].
There are strong indications that variant TRP expression
is also involved in many diseases (e.g. mutations in TRPs
are responsible for various kidney diseases), or cancer
(e.g. prostate, breast, colon, rectum) [6, 14]. Structure
function TRP relationship studies contribute to develop-
ment of novel strategies for reversing dysfunctional re-
sponses underlying various pathological conditions.
TRPs consist of six putative transmembrane do-
mains with a pore loop between the fifth and sixth
spanning segments. The span between the fifth and
sixth segments forms a conduit for cation membrane
permeation. Each channel is composed of four sub-
units that can be organized in either a heteromeric or
homomeric configuration. These different subunit
combination possibilities account for Ca2+ selectivity
variability. Various different subfamilies of TRPs are
known [7, 15–18]. Based on amino acid sequence and
functional similarities, TRP channels are divided into
seven main subfamilies: a) TRPA (ankyrin); b) TRPC
1-4 (canonical); c) TRPM1-8 (melastatin) [19, 20].
TRPM8 (originally named Trp-p8) is a cold- and
menthol-sensing Ca2+-permeable channel which plays
a crucial role in cold thermosensation; Except for
TRPM4 and TRPM5, all other TRPs are permeable to
Ca2+ [12, 21]. d) TRPML (mucolipin); e) TRPN (no
mechano potential); f ) TRPP (polycystin: g) TRPV1-7
(vanilloid) [5, 22]. Drosophila phototransduction is
mediated by a TRPC channel together with a second
TRPC channel trp-like (TRPL) [23, 24].
Impact of altered TRP expression on cellular
functions and disease states
Modulation of TRP channel activity contributes to the
control of cell growth, differentiation, proliferation or
secretion through changes in intracellular Ca2+ levels.
This can trigger downstream linked signaling pathways
controlling gene expression events underlying each of
these responses. On the other hand, aberrant enhanced
TRP channel activation leading to non-physiological
rises in extracellular calcium influx or intracellular cal-
cium release from stores (e.g. endoplasmic reticulum) by
Ca2+-release channels (e.g. IP3, ryanodine receptors) can
induce apoptosis in various cell types. For example,
Yoon et al. found that there is an extremely rapid photo-
receptor cell death when a TRP channel is constitutively
active due to mutations [25]. In the corneal endothe-
lium, changes in TRP channel activity affect its role in
maintaining tissue transparency (barrier and pump func-
tion) [26]. On the other hand, calcium overload caused
by growth factor-induced TRP channel activation can
lead to calcium overload and excessive apoptosis [27,
28]. Such a change can as well compromise organ trans-
plantation success and pathogenesis of eye diseases (e.g.
corneal dystrophy) and may contribute to donor cornea
shortage [29].
Determinants of TRP thermosensitivity
Out of the 28 mammalian TRP genes, 6 different ther-
mosensitive TRP isotypes are expressed in the eye. They
include TRPV1, 2, 3 and 4 as well as TRPM8 and TRPA1
whose temperature sensitivities cover most of the envir-
onmental conditions that mammals encounter. TRPV4
and TRPV3 are activated by temperatures from 25 to
31 °C, respectively, whereas TRPV1 is activated at 43 °C
and TRPV2 at a noxious temperature of 51 °C [30].
TRPM8 and TRPA1 on the other hand sense cooling
once the temperature drops below 25 and 17 °C, respect-
ively. It is unclear whether one of these three suggested
mechanisms can account for the origin of the remark-
ably steep temperature sensitivity of the thermo-
sensitive TRPs (thermo-TRPs). They include: 1) steep
specific temperature dependence for ligand binding;
2) temperature-induced channel rearrangement; 3)
temperature-dependent membrane tension changes
controlling channel opening [31]. A definitive explan-
ation for why only certain TRPs are thermosensitive
remains somewhat elusive. Nevertheless, a recent re-
port suggests that there are specific TRP channel mo-
lecular determinants endowing thermal sensitivity. In
Drosophila, different TRPA1 isoforms are expressed
and the requirement for TRPA1 thermal sensitivity
was linked to the expression of a specific 37-amino-
acid sequence within its intracellular region (encoded
by a single exon) [32].
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Cataloging which TRP subtypes elicit specific re-
sponses can be problematic if the characterization is
based solely on drug-induced effects. This limitation
stems from the fact that their effects are not restricted
to interacting with a single subtype. Accordingly, trans-
genic animals are used to assess the impact of either a
gain or loss of TRP function on an induced response.
Even such a precaution may be confounded by compen-
satory upregulation of another gene replacing the func-
tional loss resulting from a deleted gene. Despite these
possible caveats, current assignments of functional roles
of TRP channel subtypes appear to be accurate.
Classical activation mechanism
Initially, it was realized that either exogenous small
organic synthetic compounds or natural products can
activate TRPs. Besides capsaicin, [33] other (synthetic)
agonists are icilin (TRPM8) [34] and camphor (TRPV3)
[35, 36] which are super cooling agents. Furthermore,
endogenous lipids or products of lipid metabolism are also
ligands of TRPs. For example, anandamide is an endogen-
ous lipid [37]. Inorganic ions such as Ca2+ or Mg2+ can
also (directly) activate TRPs (e.g. TRPM6 for Mg2+) [38]
(e.g. TRPA1 for Ca2+) [39]. However, it is not yet known if
the TRP conformational changes induced by Ca2+ or Mg2+
are the same as those induced by a thermal transition
known to activate these different TRP channel sub-
types. Overall, classical activation of TRPs and in
particular thermo-TRPs are mostly related to direct
activation via mechanical stimuli, channel phosphoryl-
ation, certain exogenous and endogenous agents or
inorganic ions.
TRP channel regulation by G protein-coupled receptors
Studies in Drosophila photoreceptors by Devary et al.
demonstrated for the first time that the light activated
TRP channels and TRPL are targets of G protein-
coupled receptor (GPCR) activated rhodopsin, which
lead to activation of Gq, PLC and PIP2 hydrolysis [40].
Another study by Hardie et al. showed for the first time
that the DAG branch of PI-signaling (and PUFAs) also
activates in Drosophila TRP and TRPL channels [23].
Therefore, TRPs can also be (indirectly) activated by
GPCRs and receptor tyrosine kinases (RTKs) activating
phospholipase C (PLC). This can occur in different ways
such as generation of inositol (1,4,5) trisphosphate (IP3)
and subsequent Ca2+ release from intracellular stores,
which in turn activates store-operated Ca2+ channels
(SOCs) composed of TRP subunits such as TRPC1 and
TRPC4 [41]. Another way which GPCRs can modulate
TRP channel activity is via the generation of diacylglyc-
erol (DAG) (e.g. diacylglycerol-sensitive TRPC3/6/7)
[42]. Finally, GPCRs can modulate TRPs via hydrolysis of
phosphatidylinositol (4,5) bisphosphate (PIP2) (TRPM8)
[43] (TRPC4) [44].
TRPs in ocular tissues and cells
Uvea, retina and retinal pigment epithelium
Besides the TRP channel subtypes mediating retinal
phototransduction in the Drosophila eye [1, 2, 45, 46],
other subtypes identified in the mouse retina include:
TRPC1-4 TRPM1/3/7, TRPML1, TRPP2, TRPV2, TRPV4
[47, 48]. In mouse retinal ganglion cells (RGCs), TRPV4
modulates calcium flux, spiking rate, and apoptosis of
these cells [48]. TRPV1 in rat retina contributes to elicit-
ing RGC apoptosis and increased intracellular Ca2+
levels during exposure to elevated hydrostatic pressure
[49]. Furthermore, TRPC1 and TRPC4 are expressed in
chicken retina [50]. In the human retina, TRPM1 expres-
sion was detected on ON-bipolar cell dendrites. This
suggests a dual function for TRPM1 in the ON-pathway
[51]. More specifically, TRPM1 is required for the
photoresponse in mouse retinal ON-bipolar cells and it
is regulated by the metabotropic glutamate receptor 6
(mGulR6) cascade in ON-bipolar cells [52–56]. Many
human mutations affected this system [53]. Other TRPs
like TRPV1, TRPM8 and TRPA1 are expressed in retinal
tumor cells (retinoblastoma). On the other hand, TRPA1
is completely suppressed in a retinoblastoma cell line,
which is resistant to the cytostatic agent etoposide [57].
In addition, TRPV1-4, TRPM8 and TRPA1 were identi-
fied in retinal pigment epithelial (RPE) cells [58, 59]. In-
creasing the ambient temperature or insulin like growth
factor-1 (IGF-1) enhanced vascular endothelial growth
factor-A (VEGF-A) secretion rate in RPE cells [58].
TRPs are involved in the IGF-1 induced response [58].
Regarding the human uvea, there is only one study dem-
onstrating gene expression of TRPV1, TRPM8 and TRPA1
[59]. In contrast, in human uveal melanoma cells, the gene
expression of TRPM8 is at lower levels whereas the
TRPA1 expression is at high levels in healthy uvea [59].
Corneal epithelium
TRPC4 is the first TRP channel subtype identified in hu-
man corneal epithelial cells (HCEC). Activation by epi-
dermal growth factor of its cognate receptor, EGFR,
transactivates TRPC4. The resulting increases in intra-
cellular trigger mitogen activated protein kinase (MAPK)
cascade signaling leading to rises in cell proliferation
and migration in vitro and in vivo [60]. Conversely,
TRPV1 activation by capsaicin, induces increases in cell
proliferation and migration through mediating increases
in release of heparin bound EGF, which transactivates
EGFR [61]. TRPV1-4 vanilloid are expressed in rat, mice
and HCEC [62–64]. Thermal transitions were used to
delineate functional TRPV1-4 [65–72] and TRPM8/
TRPA1 [73, 74] expression.
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TRPV1 expression in HCEC has potential clinical rele-
vance since in TRPV1 knockout mice re-epithelialization
and restoration of tissue transparency following debride-
ment was delayed in these mice compared to their wild
type counterpart. This effect of TRPV1 in promoting cell
proliferation and migration is associated with increases
in IL-6 and substance P expression, which are coactiva-
tors of growth factor induced wound healing [62].
TRPV4 expression in intact human corneal epithelium
and its activation by exposure to a hypotonic challenge
is required for inducing regulatory cell volume decrease
behavior [75]. Furthermore, Pan et al. [76] found that
hypertonic stresses identical to those described in some
dry eye patient tears elicited TRPV1 channel stimulation
leading to rises in proinflammatory cytokine levels
through MAPK and NF-kB activation [64, 77]. TRPM8
cold receptor gene, protein and functional expression
was detected in HCEC. On the other hand, TRPM8 acti-
vation by either temperature lowering or icilin inhibits
TRPV1-induced increases in intracellular Ca2+ levels
(Türker, Mergler et al. unpublished observation 2015).
Corneal stroma
Functional TRPV1 expression was identified in human
stromal fibroblast cultures [78, 79]. Transforming
growth factor TGFβ-1 transactivates TRPV1 in these
cultures through activation of its cognate receptor,
TGFβR. In vivo, a murine corneal alkali burn compro-
mises basement membrane integrity leading to TGFβ
stromal infiltration and myofibroblast transdifferentia-
tion, fibrosis and a proinflammatory cytokine, chemo-
attractant storm followed by immune cell infiltration.
These injury-induced effects cause corneal opacification
and ulceration [80]. This marked difference in the wound
healing outcome resulting from epithelial and stromal
TRPV1 activation suggests that TRPV1 antagonist usage
in a clinical setting may need to be restricted to cases in-
volving penetrating stromal injury rather than superficial
epithelial injury. TRPM8 gene, protein and functional ex-
pression was validated in human corneal stromal cells
(Türker, Mergler et al. unpublished observation 2015).
Corneal nerve fibers
Thermosensitive TRPA1 and TRPM8 are also expressed
on corneal afferent nerves [81]. Corneal nerve fibers are
radially distributed within the stroma and the adjacent
limbus [82]. TRPV1 and TRPM8 are highly expressed in
mouse, guinea pig and human corneal sensory nerve fi-
bers at levels similar to those in their non-corneal
counterpart [81, 83–85] and in non-corneal primary
sensory neurons [30]. These channels desensitize dur-
ing prolonged exposure to capsaicin (TRPV1) or men-
thol (TRPM8). In a clinical setting, nerve fiber TRPM8
activation by a super cooling agent may provide an
option for treating dry eye syndrome since corneal
cooling in humans increased lacrimation, whereas
warming had an opposite effect [81]. Parra et al. found
that TRPM8 functional expression is needed to main-
tain ocular surface hydration during exposure to a des-
iccating stress [81]. Taken together, these results
suggest that drug-induced fibroblast TRPV1 and neur-
onal TRPM8 functional modulation may provide novel
options to lessen corneal opacification and increase lac-
rimation subsequent to a penetrating corneal injury and
in aqueous deficient dry eye disease, respectively.
Corneal endothelium
Rae and Watsky [86] described in the corneal endothe-
lium an outwardly rectifying thermosensitive current
along with a K+-selective current. The origin of the ther-
mosensitive component was not identified, but may be
attributable to TRP activity [86]. More recently, thermo-
sensitive TRPV1-4 channel activity was identified in
human corneal endothelial cells [87, 88]. Besides voltage-
operated Ca2+ channels (VOCCs) [27, 28], there is func-
tional menthol receptor TRPM8 expression in human
corneal endothelial cells because the super cooling
TRPM8 agonist icilin [34] reversibly increased intracellu-
lar Ca2+levels [89]. Besides TRPM8 expression in human
corneal endothelial cells, Mergler et al. [28] suggested that
other TRP subtypes may be also expressed in human cor-
neal endothelium since H2O2 induced significant rises in
[Ca2+]I levels. This Ca
2+ rise could be due to activation of
redox sensitive TRP subtypes mediating previously un-
explained biological phenomena and are involved in
various pathologies [90]. Corneal endothelial functional
TRPM8 expression may help explain why storing iso-
lated corneas in an eye bank setting at temperatures
below those in-situ results in less swelling than at 37 °C
[89, 91, 92]. TRPM8 stimulation could result in graded
shifts of voltage-dependent activation to more negative
membrane voltages increasing the electrical driving
force for intracellular Ca2+ influx [31]. TRPM8 may be
also regulated by G protein-coupled receptors (GPCRs)
since both activation of a GPCR and a nerve growth
factor receptor inhibited menthol- and cold-induced
TRPM8 activity in non-corneal cells [20].
Lens epithelium
Intracellular Ca2+ regulation in lens epithelial and fiber
cells is critical to lens transparency maintenance since rises
in its level are cataractogenic. Functional TRPM3 and
TRPV1 expression was identified in human lenses [93].
TRPM3 variants are associated with cataractogenesis [93].
TRPV4 expression in porcine lens epithelium regulates
hemi-channel-mediated ATP release and Na+- K+-ATPase
activity [94]. Plasma membrane associated store operated
channel (SOC) activity is modulated through changes in
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the intracellular store (ICS) Ca2+ filling status. Such feed-
back control of SOC activity is mediated by TRPC1 and
TRPC5 subtypes whose open time is prolonged following
ICS Ca2+ depletion [76].
Conjuncitval epithelial cells
In conjunctival epithelial cells, there are temperature-
sensitive TRPV1, TRPV2 as well as TRPV4 channels [95].
There are indications for crosstalk between TRPV1 and
TRPM8 since TRPM8 activation suppressed TRPV1-
induced Ca2+ increases as well as increases in proinflam-
matory cytokine IL-6 release [96].
Adaptive roles of functional TRP expression
TRPs make an important contribution to maintaining
tissue homeostasis under a variety of environmental con-
ditions that can be otherwise disruptive. In humans,
TRPs play an important role in modulating taste sensa-
tion, eliciting responses to painful stimuli, temperature,
growth factors and pheromones [97–103]. Modulation
of their activity and expression can also change the ef-
fects of stressors mediating cell death [49, 102, 104]. In
addition, store-operated Ca2+ channels (SOCs) can be
activated via intracellular store (ICS) calcium depletion
and as aforementioned by activated GPCRs or receptor-
linked tyrosine kinases (RTKs). However, their dysfunc-
tion is linked with sustained increases in cytosolic Ca2+
leading to apoptosis [97–99, 101, 105].
Healthy eyes
Worldwide, the number of people needing relief from
ocular dysfunction is on the rise. One of the reasons for
this increase is a change in lifestyle due to reliance on
video display terminals and stresses imposed by
urbanization. Corneal thermosensitive TRPV1-4, TRPA1
and TRPM8 channels in the cornea can be activated by
stresses encountered in daily living and elicit responses
that can contribute to ocular disturbances. In addition,
1) TRPV1 (capsaicin); 2) TRPV2/3 (camphor, laurel tree
cinnamomum camphora); 3) TRPV4, bisandrographolide
in Chinese herbal plant Andrographis paniculata; 4)
TRPM8, menthol in green mint; 5) TRPA1, cinnamalde-
hyde, isothiocyanates and allicin in horseradish are se-
lectively ligand gated [106]. An indication of the
adaptive value of TRPV1 expression in the cornea is that
application of capsaicin to the ocular surface elicits ex-
cruciating pain, which elicits an avoidance response to
reduce tissue injury. Thermosensitive corneal TRP ex-
pression may also provide an adaptive advantage by eli-
citing responses that reduce disruptive noxious thermal
effects on tissue homeostasis. Similar considerations are
relevant to the posterior section of the eye such as ret-
ina, uvea and retinal epithelium (RPE) since in these tis-
sues there is also thermosensitive TRP expression (e.g.
TRPV2 in RPE) [58]. On the other hand, retinal TRPV1
expression level is low compared to that in the anterior
section of the eye (e.g. lens) [107]. Furthermore, the
menthol receptor, TRPM8, provides essential functions
including contributing to controlling basal tear fluid se-
cretion via corneal nerve fibers [81, 83]. In addition, hu-
man corneal endothelial TRPM8 expression may provide
an adaptive advantage for preserving tissue function dur-
ing temperature lowering [89]. In summary, functional
thermosensitive TRP activation by environmental chal-
lenges elicits essential responses that have adaptive value
in preventing or reducing tissue function compromise.
Eye diseases
With the realization in the last decade of the polymodal
regulatory roles of TRP channels, there is heightening
interest in studying how they elicit such control. This is
evident based on the ever-increasing number of reports
appearing in Pub Med and their citation frequency. One of
the realizations sparking such interest is that TRP gene
mutations underlie numerous inherited diseases in humans
including the eye [108]. TRP channelopathies were initially
linked to cardiovascular, renal, skeletal and nervous system
pathology [108–110]. Regarding the eye, one of them deals
with mucolipidosis type IV (MLIV) and another indicates
that mutant TRPM3 expression is associated with catarac-
togenesis and glaucoma [93]. MLIV is an autosomal reces-
sive, neurodegenerative lysosomal storage disorder, which
is due to mutations in the gene MCOLN1. MLIV is clinic-
ally characterized not only by ophthalmologic abnormal-
ities such as corneal opacity, retinal degeneration and
strabismus, but also by other non-ocular abnormalities.
MCOLN1 which encodes the protein mucolipin 1 (MNL1)
is a non-specific cation channel (TRPML1) (review [111]).
In addition, human TRPM1 mutations are associated with
congenital stationary night blindness (CSNB), whose pa-
tients lack rod function and suffer from night blindness
starting in early childhood [112].
Dry eye syndrome
The options for treating dry eye syndrome (DES) are
limited for the most part to providing palliative relief.
With the identification of anterior segment functional
TRP expression illustrated in Fig. 1, there is suggestive
evidence that they are potential drug targets for improv-
ing treatment of this disease. DES or keratoconjunctivitis
sicca is a complex multifactorial disease characterized by
an immune and inflammatory process that affects the
lacrimal glands and ocular surface [113]. TRPV1 is im-
plicated as a possible drug target since TRPV1 activation
hastens corneal epithelial wound healing whereas its in-
hibition reduces stromal opacification and hypertonic-
induced inflammation [80, 114, 115]. TRPM8 activation
on afferent sensory corneal nerves and in the different
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corneal cell types enhances basal tear flow during a
decline in ambient temperature [81, 95, 115].
Diabetic retinopathy
Ocular diseases such as diabetic retinopathy can be a
manifestation of systemic diabetes mellitus. One of its
pathophysiological alterations is impaired retinal blood
flow due to vascular occlusion. This condition can
cause photoreceptor and neuronal hypoxia leading to
cell death and visual impairment. Whereas there are
various studies describing a connection between TRPs
and diabetes mellitus (review [116, 117]), there are no
studies directly related to diabetic retinopathy. On the
other hand, some are available pertaining to non-
diabetic related retinopathy (e.g. melanoma-associated
retinopathy) [112, 118, 119].
Glaucoma
In glaucoma, one of its pathological effects can includes
declines in retinal ganglion cell (RGC) function due to
intraocular pressure elevations compressing nerve fibers
traversing through the optic nerve head. Changes in
TRP function may contribute to changes in RGC func-
tion induced by such stress [49, 120]. Other tissue
changes that may contribute to glaucoma damage are
obstruction of aqueous outflow pathways through the
trabecular meshwork and/or a change in ciliary muscle
contractility. As some mechanosensitive TRPC channel
subtypes are expressed in these tissues [121], a change in
their store-operated channel activity could contribute to
trabecular meshwork (TM) pathology [76]. Functional
mechanosensitive TRPV4 expression on primary cilia in
TM cells transduces pressure changes resulting from
variations in aqueous humor formation. This subtype is
implicated in how the eye senses such variations to
maintain normostensive aqueous humor outflow Its
regulatory role suggests that TRPV4 is an attractive
therapeutic target for the treatment of hypertensive
glaucoma [121]. In another study, TRPC6 gene expres-
sion in primary open-angle glaucoma patient leukocytes
was detected. Interestingly, its expression was higher
than that in control cataract patients, which suggests
this channel subtype is a relevant biomarker for this kind
of eye disease [122]. Additionally, changes in TRPC6
gene expression level were also correlated with alter-
ations of intraocular pressure and cup-to-disc ratio.
However, treatment with different anti-glaucoma drugs
did not affect its gene expression. This negative effect il-
lustrates the complexities involved in understanding the
pathophysiology of glaucoma.
Ocular tumors
Ocular tumor development is a rare occurrence compared





















Fig. 1 TRP channels and cannabinoid receptor 1 (CB1) in the human cornea: Corneal epithelium: TRPV1/3/4 [64, 75, 140], CB1 [141], TRPC4 [60],
TRPM8 (Khajavi, Mergler et al., 2014, unpublished observation); corneal stroma: TRPV1 [78], TRPM8 (Türker, Mergler et al., 2015, unpublished
observation); corneal nerve fibers: TRPV1 [142], TRPM8 [81]; corneal endothelium: TRPV1-3 [88], TRPV4 [87]; TRPM8 [89], TRPA1 [89]
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corneal neovascularization, this process is not directly re-
lated to tumor neovascularization. Nevertheless, neovas-
cularization is a dangerous process whose progression
determines tumor growth and metastasis. Endothelial cells
(ECs) play a role in neovascularization and several differ-
ent TRP subtypes have been detected in this tissue (review
[123]). At this point, Ca2+ channel drug targeting is being
considered in non-ocular tissues (review [124, 125]) and
ocular tissues, but findings in these studies are unrelated
to tumor neovascularization. One study showed that
blockage of Ca2+ activated K+ channels inhibited angio-
genesis induced by epidermal growth factor (EGF) [126].
In retinal pigment epithelium (RPE), activation of L-type
Ca2+ channels is associated with increases in vascular
endothelial growth factor (VEGF) secretion. Additionally,
basic fibroblast growth factor (bFGF) increased L-type
channel activity [127, 128]. A follow-up study demon-
strated in the RPE that TRPV2 channels mediate increases
in both heat-dependent and IGF-1 (via PI3-kinase activa-
tion)-induced VEGF secretion through rises in intracellu-
lar Ca2+ levels.
Uveal melanoma
Uveal melanoma (UM) is a devastating disease in which
patient survival rates are poor once this tumor metasta-
sizes out of the eye into the liver, lung, bone and skin. It
is the second most prevalent malignant tumor of melano-
cytes [129, 130]. This disease directly develops from degen-
erated melanocytes in the choroid. TRPs expression was
identified in healthy non-ocular and ocular melanocytes
[131]. Specifically, TRPM1 was designated as a melanoma
metastasis suppressor based on its expression in normal
pigment cells in the skin and its absence in aggressive ocu-
lar metastatic -competent melanomas. A similar associ-
ation pertains to TRPA1 because its expression is lower in
human uveal melanoma cells than in healthy uvea [59]. An
inverse relationship was described for TRPM8 which is
expressed at higher levels in most of the investigated UM
cell lines [59]. Furthermore, TRPV1 and the cannabinoid
receptor 1 (CB1) are functionally expressed in UM cells.
Interestingly, activation of CB1 induced Ca2+ transients,
which were suppressed by either La3+, a non-selective TRP
channel blocker and capsazepine, a selective TRPV1 antag-
onist. On the other hand, capsaicin-induced Ca2+ tran-
sients could also be suppressed by CB1 activation.
Therefore, it is suggested that identification of functional
TRPV1, TRPM8, TRPA1 and CB1 expression in uveal mel-
anoma may provide novel drug targets for treatment of this
aggressive neoplastic disease [59]. A similar suggestion was
made for treating non-uveal melanoma (TRPM8) [132].
Retinoblastoma
Figure 2 provides an illustrative representation of the
different TRP subtypes expressed in the retina. Retino-
blastoma (RB) is a malignant retinal tumor, which de-
velops from immature retinal cells. Its incidence is low,
but is the most common ocular tumor of the eye in chil-
dren and is associated with a RB mutation [133]. There
are several established cell lines that serve as retinoblast-
oma cell models exhibiting voltage-dependent ion channel
Fig. 2 TRP channels and CB1 in the posterior section of the eye: Retina: TRPV1 [57], CB1 [57], TRPM7 [139], TRPM8 [57], TRPA1 [57], TRPM1 [51].
TRPs marked with an asterisk were detected in retinoblastoma cells. Interestingly, TRPA1 could not be detected in etoposide-resistant retinoblastoma
cells [57]; retinal pigment epithelium: TRPV1 [58, 59], TRPV2-4 [58], TRPM8 [58], TRPMA1 [58]; choroid: TRPV1 and CB1 [58], TRPM8 and TRPA1 [58], TRPs
marked with an asterisk were also detected in uveal melanoma cells. Notably, the gene expression of TRPM8 is at lower levels in uveal melanoma cells
whereas the TRPA1 expression is at higher levels in healthy uvea [58]
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activity [134–138]. Specifically, the Ca2+ channel antagonist
mibefradil inhibited cell proliferation via different cytotoxic
pathways mediated by voltage-dependent T-type Ca2+
channels [136]. Regarding Ca2+ permeable TRPs, Hanano
et al. suggested a possible significant regulatory role of
TRPM7 for retinoblastoma cell proliferation as a spontan-
eously activated Ca2+ influx pathway [139]. Another study
revealed TRPV1, TRPM8 and TRPA1 gene expression in
retinoblastmoa cells [57]. Notably, the expression of TRPA1
was suppressed in etoposide-resistant RB cells. Therefore,
using genetic approaches to upregulate TRPA1 expression
could provide a means to induce etoposide sensitivity and
suppress RB cell tumorigenesis. Furthermore, CB1 was de-
tected in uveal melanoma cells. Activation of CB1
suppressed TRPV1-induced Ca2+ increases in etoposide-
sensitive RB cells whereas this effect did not occur in
etoposide-resistant RB cells [57]. There have been only a
few reports describing a TRP involvement whereas other
types of Ca2+ channels have been studied more extensively.
Nevertheless, the limited TRP characterizations suggest
that there are clear differences between healthy and tumor-
ous ocular tissues or cytostatic-resistant ocular tissue.
Therefore, modulation of TRP expression and/or function
could provide a badly needed therapeutic option. In
addition, monitoring TRP expression levels could provide a
prognostic marker for identifying this insidious disease.
Conclusion
Ocular TRP functional expression is essential for medi-
ating both adaptive and maladaptive responses to a wide
variety of environmental stressors challenging tissue
homeostasis. Table 1 lists ocular tissue TRP subtype
localization and pharmacology described in pertinent
references. It is still uncertain how the activation of a







Function [5, 30] Posterior eye section Anterior eye section
TRPC1 Non-selective --- Store depletion,
2-APB
Component of SOC Mouse retina [47, 48] HCEC [60], TM [121]
TRPC2 2.7 --- DAG ? Mouse retina [47, 48] TM [121]
TRPC3 1.6 --- Store depletion, OAG,
2-APB, DAG, Pyr3
Component of SOC Mouse retina [47, 48] HCEC [60], TM [121]
TRPC4 1.1–9.0 --- Store depletion
2-APB
Component of SOC Mouse retina [47, 48] HCEC [60]




Rat retina [49], human
retina (tumor) [57],
uvea (tumor) [59],
human RPE [58, 59]
HCEC [63, 64], HCK
[78], HCEC-12 [88]
TRPV2 1–3 >52 Cannabidiol, 2-APB Heat sensor Human RPE [58] HCEC-12 [88]
TRPV3 2,6 30–39 Camphor, 2-APB Moderate heat
sensor
Human RPE [58] HCEC [144],
HCEC-12 [88]







HCEC-12 [87], HLE [94]
TRPM1 Not determed --- mGluR6 Transduction of light
signals
Mouse retina [47, 48, 145],
human retina [51]
---
TRPM2 0.5–1.6 H2O2, ADP-ribose,
β-NAD+
Mechanotransduction --- HCEC-12 [28],
TM [121]
TRPM7 3 --- Spermine Mouse retina [47, 48],
human retina [139]
---
TRPM8 1–3.3 <23–28 Menthol, icilin,
eucalyptol, BCTC
Moderate cold sensor Human retina (tumor) [57],
uvea (tumor) [59]
HCECcHCNF [81],
HCKc, HCEC-12 [28, 89]




HCEC human corneal epithelium
HCK human corneal keratocytes (stroma)
HCEC-12 human corneal endothelium
TM trabecular meshwork
HCNF human corneal nerve fibers
HLE human lens epithelium
RPE retinal pigment epithelium
RGC retinal ganglion cells
aactivation by hypertonic challenge
bactivation by hypotonic challenge
cMergler et al. 2015 (unpublished data)
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single TRP subtype by diverse stimuli can mediate a
number of different signaling pathways and diverse re-
sponses. One tenable explanation is that TRP subtypes
can have specific molecular determinants with which ac-
tivators interact. In other words, it still needs to be
understood whether there are specific determinants on a
TRP subtype that induce each of the different responses
attributable to its activation. Each of these different sites
may be linked to diverse signaling pathways mediating
variety of different responses. Verification of this possi-
bility requires generating site specific TRP mutants to
determine if such alterations correspond with any of the
pathophysiological responses by cells expressing TRPs.
One example of such an approach would entail delineat-
ing why capsazepine interaction with TRPV1 in one set-
ting suppresses injury-induced inflammation, but in
another setting it instead elevates body temperature.
Nevertheless, based on the burgeoning number of TRP-
related publications and commitments pharmaceutical
companies are making to identify novel lead compounds
for future drug development, it is conceivable that ocular
disease management may benefit from such endeavors.
This appears to be tenable since there are indications
that there is an association between aberrant TRP ex-
pression and disease. In any case, much effort must still
be committed to determine if there is a cause and effect
relationship between specific TRP malfunctions and a
pathophysiological condition underlying a eye disease.
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